perampanel and Headache-Disorders

In 2013, perampanel is approved as an add-on treatment for generalised and focal seizures in pharmaco-resistant epilepsy. New anticoagulants are superior to antivitamin K in stroke secondary prevention in case of atrial fibrillation. DBS remains a valid therapeutic option for advanced Parkinson's disease. Intranasal ketamine seems to reduce the intensity of severe migraine aura. High concentrations of topic capsaicin improve post-herpetic neuralgia. In Alzheimer's disease, statins might deteriorate cognitive functions. Oral immuno-modifing treatments for relapsing remitting multiple sclerosis have shown to slow cerebral atrophy progression at two years.

Topics: Central Nervous System Agents; Cerebrovascular Disorders; Deep Brain Stimulation; Epilepsy; Headache Disorders; Humans; Movement Disorders; Neurology; Neuromuscular Diseases; Nitriles; Pyridones